Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people in over 100 countries at Sanofi are dedicated to make a difference in patients' daily life, wherever they live and enable them to enjoy a healthier life. As a company with a global vision of drug development and a highly regarded corporate culture, Sanofi is recognized as one of the best pharmaceutical companies in the world and is pioneering the application of Artificial Intelligence (AI) in the R&D organisation including drug discovery, chemical manufacturing and control, translational research, clinical development, and regulatory document management and submission.
The In Silico Design group, within the Integrated Drug Discovery unit, develops and applies Machine Learning algorithms to drug discovery programs. Group members have recently published, e.g. on molecular generation under scaffold constraints and on the predictability of reaction yields. The fellows will be integrated within a dense and international network of inhouse experts in drug design as well as in computational methods development and deployment.